Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology
Publisher: National Academies Press 2013
Number of pages: 100
Genome-Based Diagnostics assesses the evidentiary requirements for clinical utility of molecular diagnostics used to guide treatment decisions for patients with cancer; discusses methodologies related to demonstrating these evidentiary requirements that meet the needs of all stakeholders; and considers innovative, sustainable research collaborations for generating evidence of clinical utility involving multiple stakeholders.
Home page url
Download or read it online for free here:
- International Agency for Research on Cancer
This volume provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin, pioglitazone and hydrochlorothiazide.
by H. Reeves, D.M. Manas, R. Lochan (eds) - InTech
The prognosis for individuals with liver cancer is frequently poor. The topic of liver tumors is comprehensively reviewed in this book, with a focus on recent developments and improved techniques relevant to both researchers and clinicians.
by S. Nass, H. Moses - National Academies Press
Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured. There is tremendous opportunity to improve the outcome for people with cancer by enhancing detection and treatment approaches.
by Robyn Dewis, Jonathan Gribbin - National Collaborating Centre for Cancer
This is a summary of the current information available regarding the epidemiology of breast cancer regionally, nationally and internationally. Its purpose is to provide the guidelines on early and locally advanced and advanced breast cancer.